CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Clinical epidemiology of heart failure with preserved ejection fraction (HFpEF) in comparatively young hospitalized patients Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery Dapagliflozin for treating chronic heart failure with reduced ejection fraction Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"

Original Research2016 Jan 1;202:918-21.

JOURNAL:Int J Cardiol. Article Link

Clinical epidemiology of heart failure with preserved ejection fraction (HFpEF) in comparatively young hospitalized patients

Zacharias M1, Joffe S, Goldberg RJ et al. Keywords: acute heart failure; population-based study; young vs. older patients

FULL TEXT PDF